middle.news
How Will Chimeric’s $6.6M Raise Accelerate Its Cancer Cell Therapies?
2:07am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
How Will Chimeric’s $6.6M Raise Accelerate Its Cancer Cell Therapies?
2:07am on Monday 2nd of June, 2025 AEST
Key Points
Placement raises $6.6 million at $0.004 per share with attaching and contingent options
Funds to advance CHM CDH17 CAR-T dose escalation and CORE-NK Phase 1B trials
Strong institutional demand led to scaled-back investor allocations
US-based family office provides cornerstone support
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Chimeric Therapeutics (ASX:CHM)
OPEN ARTICLE